PCN15 CAPECITABINE VS. BOLUS 5-FU/LV AS ADJUVANT THERAPY...

PCN15 CAPECITABINE VS. BOLUS 5-FU/LV AS ADJUVANT THERAPY FOR PATIENTS WITH DUKES' C COLON CANCER: PHARMACOECONOMIC EVALUATION OF X-ACT TRIAL– DATA FROM CZECH PERSPECTIVE

L Jiraskova, T Dolezal
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
9
Year:
2006
Language:
english
DOI:
10.1016/s1098-3015(10)63445-6
File:
PDF, 69 KB
english, 2006
Conversion to is in progress
Conversion to is failed